For: | Formica V, Cereda V, Nardecchia A, Tesauro M, Roselli M. Immune reaction and colorectal cancer: Friends or foes? World J Gastroenterol 2014; 20(35): 12407-12419 [PMID: 25253941 DOI: 10.3748/wjg.v20.i35.12407] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v20/i35/12407.htm |
Number | Citing Articles |
1 |
Vincenzo Formica, Cristina Morelli, Veronica Conca, Maria Alessandra Calegari, Jessica Lucchetti, Emanuela Dell’Aquila, Marta Schirripa, Marco Messina, Lisa Salvatore, Federica Lo Prinzi, Giovanni Dima, Giovanni Trovato, Silvia Riondino, Mario Roselli, Ferdinandos Skoulidis, Hendrik-Tobias Arkenau, Chiara Cremolini. Irinotecan- vs. Oxaliplatin-Based Doublets in KRASG12C-Mutated Metastatic Colorectal Cancer—A Multicentre Propensity-Score-Matched Retrospective Analysis. Cancers 2023; 15(11): 3064 doi: 10.3390/cancers15113064
|
2 |
I. V. Feldblum, M. H. Alyeva, A. O. Kanina, V. N. Gryaznov, D. V. Zitta. Epidemiological Evaluation of Colorectal Cancer Risk Factors Associated with the Sources of Water Consumption and the Some Features of Diet in Perm Krai. Epidemiology and Vaccine Prevention 2015; 14(5): 44 doi: 10.31631/2073-3046-2015-14-5-44-50
|
3 |
Mostafa Vaghari-Tabari, Niloufar Targhazeh, Soheila Moein, Durdi Qujeq, Forough Alemi, Maryam Majidina, Simin Younesi, Zatollah Asemi, Bahman Yousefi. From inflammatory bowel disease to colorectal cancer: what’s the role of miRNAs?. Cancer Cell International 2022; 22(1) doi: 10.1186/s12935-022-02557-3
|
4 |
Wu Bi, Haibo Liu, Jie Shen, Ling-hua Zhang, Pei Li, Bing Peng, Li Cao, Pengfei Zhang, Chunnian He, Peigen Xiao. Chemopreventive effects of Ku-jin tea against AOM-induced precancerous colorectal lesions in rats and metabolomic analysis. Scientific Reports 2017; 7(1) doi: 10.1038/s41598-017-16237-0
|
5 |
Shuping Long, Yi Yang, Chengpin Shen, Yiwen Wang, Anmei Deng, Qin Qin, Liang Qiao. Metaproteomics characterizes human gut microbiome function in colorectal cancer. npj Biofilms and Microbiomes 2020; 6(1) doi: 10.1038/s41522-020-0123-4
|
6 |
Marija Mihajlović, Ana Ninić, Marija Ostojić, Miron Sopić, Aleksandra Stefanović, Jelena Vekić, Tamara Antonić, Dejan Zeljković, Bratislav Trifunović, Vesna Spasojević-Kalimanovska, Nataša Bogavac Stanojević, Ivan Jančić, Aleksandra Zeljković. Association of Adiponectin Receptors with Metabolic and Immune Homeostasis Parameters in Colorectal Cancer: In Silico Analysis and Observational Findings. International Journal of Environmental Research and Public Health 2022; 19(22): 14995 doi: 10.3390/ijerph192214995
|
7 |
Antonio Manuel Burgos-Molina, Teresa Téllez Santana, Maximino Redondo, María José Bravo Romero. The Crucial Role of Inflammation and the Immune System in Colorectal Cancer Carcinogenesis: A Comprehensive Perspective. International Journal of Molecular Sciences 2024; 25(11): 6188 doi: 10.3390/ijms25116188
|
8 |
Milan Jovanovic, Nevena Gajovic, Natasa Zdravkovic, Marina Jovanovic, Milena Jurisevic, Danilo Vojvodic, Veljko Maric, Aleksandar Arsenijevic, Ivan Jovanovic. Fecal Galectin-3: A New Promising Biomarker for Severity and Progression of Colorectal Carcinoma. Mediators of Inflammation 2018; 2018: 1 doi: 10.1155/2018/8031328
|
9 |
Vincenzo Formica, Cristina Morelli, Patrizia Ferroni, Antonella Nardecchia, Manfredi Tesauro, Stefania Pellicori, Vittore Cereda, Antonio Russo, Silvia Riondino, Fiorella Guadagni, Mario Roselli. Neutrophil/lymphocyte ratio helps select metastatic pancreatic cancer patients benefitting from oxaliplatin. Cancer Biomarkers 2016; 17(3): 335 doi: 10.3233/CBM-160645
|
10 |
Qian-Qian Zhang, Xi-Wen Hu, Yi-Long Liu, Zhi-Jin Ye, Yi-He Gui, Da-Lei Zhou, Cui-Ling Qi, Xiao-Dong He, Honglin Wang, Li-Jing Wang. CD11b deficiency suppresses intestinal tumor growth by reducing myeloid cell recruitment. Scientific Reports 2015; 5(1) doi: 10.1038/srep15948
|
11 |
Shashanka K. Prasad, Smitha Bhat, Dharini Shashank, Akshatha C. R., Sindhu R., Pornchai Rachtanapun, Devananda Devegowda, Prasanna K. Santhekadur, Sarana Rose Sommano. Bacteria-Mediated Oncogenesis and the Underlying Molecular Intricacies: What We Know So Far. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.836004
|
12 |
Egbert H van Herk, Anje A te Velde. Treg subsets in inflammatory bowel disease and colorectal carcinoma: Characteristics, role, and therapeutic targets. Journal of Gastroenterology and Hepatology 2016; 31(8): 1393 doi: 10.1111/jgh.13342
|
13 |
Haonan Zhang, Yulu Shi, Chanchan Lin, Chengcheng He, Shanping Wang, Qingyuan Li, Yan Sun, Mingsong Li. Overcoming cancer risk in inflammatory bowel disease: new insights into preventive strategies and pathogenesis mechanisms including interactions of immune cells, cancer signaling pathways, and gut microbiota. Frontiers in Immunology 2024; 14 doi: 10.3389/fimmu.2023.1338918
|
14 |
Lichao Cao, Ying Ba, Fang Chen, Shenrui Zhang, Hezi Zhang. Exploration of bacterial lipopolysaccharide-related genes signature based on T cells for predicting prognosis in colorectal cancer. Aging 2024; doi: 10.18632/aging.206041
|
15 |
Kristin M. V. Herstad, Gjermund Gunnes, Runa Rørtveit, Øyvor Kolbjørnsen, Linh Tran, Ellen Skancke. Immunohistochemical expression of β-catenin, Ki67, CD3 and CD18 in canine colorectal adenomas and adenocarcinomas. BMC Veterinary Research 2021; 17(1) doi: 10.1186/s12917-021-02829-6
|
16 |
Gerardo Ramírez-Rico, Maria Elisa Drago-Serrano, Nidia León-Sicairos, Mireya de la Garza. Lactoferrin: A Nutraceutical with Activity against Colorectal Cancer. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.855852
|
17 |
Asma Ismail Mahmod, Shatha Khaled Haif, Ayah Kamal, Israa A. Al-ataby, Wamidh H. Talib. Chemoprevention effect of the Mediterranean diet on colorectal cancer: Current studies and future prospects. Frontiers in Nutrition 2022; 9 doi: 10.3389/fnut.2022.924192
|
18 |
Vincenzo Formica, Mario Roselli. Targeted therapy in first line treatment of RAS wild type colorectal cancer. World Journal of Gastroenterology 2015; 21(10): 2871-2874 doi: 10.3748/wjg.v21.i10.2871
|